HIMS: Napoleon Watches Moscow Burn
The author believes that Hims & Hers Health's (HIMS) venture into the GLP-1 market is reaching its peak and that a significant decline is imminent. The analysis suggests that the company's strategy is overextended and that the market is not fully appreciating the risks involved.
Automatically collect high-quality investment opinions from across the web daily
Over 50+ high-quality investment ideas await you every day
Investment insights from 15+ platforms like Substack, Seeking Alpha, X/Twitter, with AI-powered summaries, categorized by industry. Register for free to access all features.